Aucun événement à venir
-
information fournie par 31 oct. 2023 00:00
Publication rapport semestriel
-
information fournie par 14 sept. 2023 14:30
Assemblée générale annuelle
-
information fournie par 31 juil. 2023 00:00
Publication rapport annuel
-
Woippy (France) – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce today the official appointment of the company and its exclusive ... Lire la suite
-
Barcelona, Spain, 29 April 2024 – MGI Tech (MGI), a company committed to building core tools and technology to lead life science, today introduced the latest addition to its range of sequencers, the portable and easy-to-use DNBSEQ-E25 platform, for the European ... Lire la suite
-
ABL DIAGNOSTICS (ticker ABLD, ISIN FR001400AHX6), Euronext Compartiment B), annonce avoir signé un contrat de liquidité avec la société ALLInvest Securities, qui prendra effet le 24/04/2024 au matin. Ce contrat de liquidité a été conclu conformément à la charte ... Lire la suite
-
Newburyport (MA, USA) – AdvancedDx Biological Laboratories USA Inc., an affiliate of ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories, is pleased to ... Lire la suite
-
Newburyport (MA, USA) – AdvancedDx Biological Laboratories USA Inc., an affiliate of ABL Diagnostics S.A. (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased ... Lire la suite
-
Woippy (France) – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is announcing today the execution of a distribution agreement conferring to PALEX ... Lire la suite
-
ABL Diagnostics (FR001400AHX6) ("ABLD" ou la "Société") a annoncé aujourd'hui que, depuis août 2023, trois cessions, pour un total de 59 651 de ses actions ordinaires, ont été déclarées à ONDE, le système central de dépôt d'informations de l'Autorité des Marchés ... Lire la suite
-
Woippy (France) – ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to announce today the execution of an exclusive distribution agreement ... Lire la suite
-
▪ Access to a comprehensive Next Generation Sequencing (NGS) kit for HIV Whole Genome genotyping. ▪ Ability to screen genomic variations in all HIV-1 genome genes targeted by current and under development HIV-1 inhibitors. Newburyport (MA, USA) – AdvancedDx Biological ... Lire la suite
-
Newburyport (MA, USA) – AdvancedDx Biological Laboratories USA Inc., an affiliate of ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories is pleased to ... Lire la suite